|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Monogenic Diabetes (MODY) 5-Gene Evaluation
Test Code92344
CPT Codes
81404 (x2), 81405 (x2), 81406 (x2), 81479<br>Limited Access Code
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Includes
Genes included: GCK, HNF4A, IPF1, HNF1A, HNF1B
Preferred Specimen
8 mL whole blood collected in two EDTA (lavender-top) tubes, or
Pediatric volume: 2 mL whole blood
Pediatric volume: 2 mL whole blood
Minimum Volume
6 mL • 1 mL pediatric
Instructions
Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing. Patients 0-3 years have higher WBC, yielding more DNA per mL of blood.
Transport Container
EDTA (lavender-top) x2
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 10 days
Refrigerated: 10 days
Frozen: Unacceptable
Refrigerated: 10 days
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received frozen
Methodology
Sanger Sequencing • Multiplex Ligation-dependent Probe Amplification (MLPA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Athena Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Varies; Report available: 14-28 days
Reference Range
No sequence variation or deletion detected
Clinical Significance
Detects deletions in the HNF4A, GCK, HNF1A, HNF1B genes and mutations in the HNF4A, GCK, HNF1A, HNF1B and IPF1
Typical Presentation: Non-ketotic hyperglycemia in non-obese individuals of any age
Indications for testing: Non-ketotic insulin-sensitive hyperglycemia in individuals of any age; Family history of diabetes.